公司概覽
業務類別 Biotechnology
業務概覽 Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic, and neuropsychiatric disorders by modulating the effect of the cortisol hormone. The company markets Korlym (mifepristone) tablets and its authorized generic version, which is an oral medication for the treatment of hypercortisolism (also known as Cushing's syndrome). Additionally, its pipeline contains several key compounds, such as Relacorilant, Dazucorilant, Miricorilant, etc., that are being evaluated in clinical trials as potential treatments for a variety of serious disorders like hypercortisolism, solid tumors (including ovarian, endometrial, cervical, pancreatic, and prostate cancers), ALS, and MASH.
公司地址 101 Redwood Shores Parkway, Redwood City, CA, USA, 94065
電話號碼 +1 650 327-3270
傳真號碼 +1 650 327-3218
公司網頁 https://www.corcept.com
員工數量 730
 
公司高管 / 董事會成員
公司高管
高管 職務 年薪 更新日期
Dr. Joseph K. Belanoff, M.D. Director, President and Chief Executive Officer 美元 1.18M 17/04/2026
Mr. G. Charles Robb Chief Business Officer and Secretary 美元 711.41K 17/04/2026
Mr. Atabak Mokari Chief Financial Officer and Treasurer 美元 566.35K 17/04/2026
Mr. Joseph Douglas Lyon Chief Accounting Officer and Chief Technology Officer -- 17/04/2026
Dr. Hazel Hunt, PhD Chief Scientific Officer -- 17/04/2026
Dr. William Guyer, Pharm.D. Chief Development Officer 美元 706.39K 17/04/2026
Mr. Justin Gunn President, Corcept Endocrinology -- 23/09/2026
 
董事會成員
董事會 職務 更新日期
Mr. David L. Mahoney Independent Director 17/04/2026
Mr. Daniel N. Swisher,Jr Independent Director 17/04/2026
Mr. George Leonard Baker, Jr Independent Director 17/04/2026
Dr. Gregg H. Alton, J.D. Independent Director 17/04/2026
Dr. Joseph K. Belanoff, M.D. Director, President and Chief Executive Officer 17/04/2026
Mr. James N. Wilson Chairman of the Board 17/04/2026
Ms. Kimberly Park Independent Director 17/04/2026
Mr. Joshua M. Murray Independent Director 17/04/2026
 
所屬ETF (更新日期: 07/11/2026 04:23)
代號 名稱 佔比% ▼ 持有日期
DFACDimensional US Core Equity 2 ETF0.04%02/10/2026
RECSColumbia Research Enhanced Core ETF0.04%31/10/2026
PTHInvesco Dorsey Wright Healthcare MomtETF0.04%30/10/2026
FCUSPinnacle Focused Opportunities ETF0.03%30/10/2026
ESMLiShares ESG Aware MSCI USA Small-Cap ETF0.03%30/10/2026
FNXFirst Trust Mid Cap Core AlphaDEX® ETF0.03%29/10/2026
ISCGiShares Morningstar Small-Cap Growth ETF0.03%30/10/2026
BBSCJPMorgan BetaBuilders US Sml Cp Eq ETF0.03%30/10/2026
FNYFirst Trust Mid Cap Growth AlphaDEX® ETF0.03%29/10/2026
ONEQFidelity Nasdaq Composite ETF0.02%30/10/2026
IWViShares Russell 3000 ETF0.02%30/10/2026
USVMVictoryShares US Sm Md Cp Val Momt ETF0.02%30/10/2026
JHMMJHancock Multifactor Mid Cap ETF0.02%30/10/2026
ESGVVanguard ESG US Stock ETF0.02%30/09/2026
SPTMState StreetSPDRPortS&P1500CompStkMktETF0.02%30/10/2026
SURISimplify Propel Opportunities ETF0.02%30/10/2026
VONEVanguard Russell 1000 ETF0.02%30/09/2026
BKMCBNY Mellon US Mid Cap Core Equity ETF0.02%31/10/2026
DWASInvesco Dorsey Wright SmallCap Momt ETF0.01%30/10/2026
ETHOAmplify Etho Climate Leadership U.S. ETF0.01%30/10/2026
  1    2   3    4    5    6    7    8    9    10  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.